-
1
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models
Published 2025-04-01“…npj Gut and Liver…”
Get full text
Article -
2
Rearrangement of the liver ubiquitome and NEDDylome in metabolic dysfunction-associated steatotic liver disease
Published 2025-08-01“…npj Gut and Liver…”
Get full text
Article -
3
Pathophysiology, noninvasive diagnostics and emerging personalized treatments for metabolic associated liver diseases
Published 2025-08-01“…npj Gut and Liver…”
Get full text
Article -
4
Automated digital analysis of propagated contractions recorded during fasting using high resolution small intestinal manometry in healthy participants
Published 2025-07-01“…npj Gut and Liver…”
Get full text
Article -
5
Pyrimidinetrione benzodioxol ameliorates MAFLD-induced liver tumorigenesis and mood disorders in mice
Published 2025-06-01“…npj Gut and Liver…”
Get full text
Article -
6
Association of metabolic abnormalities and the risk of hepatic fibrosis
Published 2025-06-01“…npj Gut and Liver…”
Get full text
Article -
7
MicroRNA in intestinal tight junction regulation
Published 2025-05-01“…npj Gut and Liver…”
Get full text
Article -
8
Scores to predict steatotic liver disease – correlates and outcomes in older adults
Published 2025-04-01“…npj Gut and Liver…”
Get full text
Article -
9
Exploring the trimethylamine pathway in advanced chronic liver disease
Published 2025-07-01“…npj Gut and Liver…”
Get full text
Article -
10
A retrospective study on colorectal lesion risk assessment in patients with early oesophagogastric cancer
Published 2025-07-01“…npj Gut and Liver…”
Get full text
Article -
11
Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults
Published 2025-05-01“…npj Gut and Liver…”
Get full text
Article